Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-17

Clinical Trial Update: Topical Application of AS101 for the Treatment of Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating topical AS101 for atopic dermatitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AS101

Snippet

Sponsor: BioMAS Ltd | Conditions: Atopic Dermatitis | Phase 2 | Status: TERMINATED